Eric M. Dube, CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc. (TVTX), sold 38,244 shares at $8.86 ($333K) on 2024-02-01, disclosed to the SEC on 2024-02-02.
Seasonal sale ($333k) by CHIEF EXECUTIVE OFFICER — this insider has traded TVTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.53 | 9,106 | $78K | 23.3% |
| 2 | $8.53 | 9,106 | $78K | 23.3% |
| 3 | $8.86 | 10,016 | $89K | 26.7% |
| 4 | $8.86 | 10,016 | $89K | 26.7% |
| Total | $8.70 avg | 38,244 | $333K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |